Genprex

GNPX

Market cap $3.94M

GNPX Hedge Fund Activity: Q1 2026 in Review

15 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2026, worth a combined $165K — up 1,170% from $13K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNPX positions and 4 closed out — a net gain of 6 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $72.2K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.74K sold.

• 15 institutional investors held Genprex (GNPX) as of Q1 2026, up from 9 in Q4 2025.
• Funds reported $165K of Genprex stock for Q1 2026, up 1,170% quarter-over-quarter.
• 10 funds opened new Genprex positions in Q1 2026 and 4 closed out, a net change of +6 holders.
• The largest Genprex buyer in Q1 2026 was Geode Capital Management, an estimated $72.2K added.
• The largest Genprex seller in Q1 2026 was Tower Research Capital (TRC), an estimated $5.74K sold.

Based on aggregated 13F filings for Q1 2026.